Cargando…
Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361614/ http://dx.doi.org/10.1038/sj.bjc.6602755 |
| _version_ | 1782153257004564480 |
|---|---|
| author | Sobrero, A Frassineti, G Falcone, A Dogliotti, L Rosso, R Di Costanzo, F Bruzzi, P |
| author_facet | Sobrero, A Frassineti, G Falcone, A Dogliotti, L Rosso, R Di Costanzo, F Bruzzi, P |
| author_sort | Sobrero, A |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2361614 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2005 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-23616142009-09-10 Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer Sobrero, A Frassineti, G Falcone, A Dogliotti, L Rosso, R Di Costanzo, F Bruzzi, P Br J Cancer Corrigendum Nature Publishing Group 2005-09-19 2005-09-13 /pmc/articles/PMC2361614/ http://dx.doi.org/10.1038/sj.bjc.6602755 Text en Copyright © 2005 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Corrigendum Sobrero, A Frassineti, G Falcone, A Dogliotti, L Rosso, R Di Costanzo, F Bruzzi, P Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer |
| title | Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer |
| title_full | Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer |
| title_fullStr | Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer |
| title_full_unstemmed | Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer |
| title_short | Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer |
| title_sort | adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage iii and high-risk stage ii colon cancer |
| topic | Corrigendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361614/ http://dx.doi.org/10.1038/sj.bjc.6602755 |
| work_keys_str_mv | AT sobreroa adjuvantsequentialmethotrexate5fluorouracilvs5fluorouracilplusleucovorininradicallyresectedstageiiiandhighriskstageiicoloncancer AT frassinetig adjuvantsequentialmethotrexate5fluorouracilvs5fluorouracilplusleucovorininradicallyresectedstageiiiandhighriskstageiicoloncancer AT falconea adjuvantsequentialmethotrexate5fluorouracilvs5fluorouracilplusleucovorininradicallyresectedstageiiiandhighriskstageiicoloncancer AT dogliottil adjuvantsequentialmethotrexate5fluorouracilvs5fluorouracilplusleucovorininradicallyresectedstageiiiandhighriskstageiicoloncancer AT rossor adjuvantsequentialmethotrexate5fluorouracilvs5fluorouracilplusleucovorininradicallyresectedstageiiiandhighriskstageiicoloncancer AT dicostanzof adjuvantsequentialmethotrexate5fluorouracilvs5fluorouracilplusleucovorininradicallyresectedstageiiiandhighriskstageiicoloncancer AT bruzzip adjuvantsequentialmethotrexate5fluorouracilvs5fluorouracilplusleucovorininradicallyresectedstageiiiandhighriskstageiicoloncancer |